Last reviewed · How we verify
Procure
At a glance
| Generic name | Procure |
|---|---|
| Sponsor | Life Research Technologies GmbH |
| Modality | Biologic |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma (PHASE2)
- Release Kinetics of rhBMP-2 Using E-PRF as an Autologous Carrier: An In Vitro Analysis
- DCD IIT: Evaluating the Safety of Utilizing Donor Hearts From Donation After Circulatory Death (DCD) Donors (NA)
- Patient Reported Outcomes After Surgery for Rectal Endometriosis
- Longitudinal Assessment of Genomic Alterations and Clonal Evolution in ALK-positive NSCLC (Galileo Project)
- Parathyroid Allotransplant for Severe Refractory Hypoparathyroidism (NA)
- Evaluation of Pancreatic Cystic Lesions Via EUS-guided Fine Needle Aspiration With and Without Micro Forceps Biopsies (NA)
- Access to EyeGlasses for School-aged Children (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Procure CI brief — competitive landscape report
- Procure updates RSS · CI watch RSS
- Life Research Technologies GmbH portfolio CI